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SUMMARY  
Modular polyketide synthases and nonribosomal peptide synthetases are molecular assembly 
lines consisting of several multienzyme subunits that undergo dynamic self-assembly to form 
a functional mega-complex. N- and C-terminal docking domains are usually responsible for 
mediating interactions between subunits. Here we show that communication between two 
nonribosomal peptide synthetase subunits responsible for chain release from the enacyloxin 
polyketide synthase, which assembles an antibiotic with promising activity against 
Acinetobacter baumannii, is mediated by an intrinsically disordered short linear motif and a 
ß-hairpin docking domain. The structures, interactions and dynamics of these subunits are 
characterised using several complementary biophysical techniques, providing extensive 
insights into binding and catalysis. Bioinformatics analyses reveal that short linear motif/ß-
hairpin docking domain pairs mediate subunit interactions in numerous nonribosomal peptide 
and hybrid polyketide-nonribosomal peptide synthetases, including those responsible for 
 assembling several important drugs. Short linear motifs and ß-hairpin docking domains from 
heterologous systems are shown to interact productively, highlighting the potential of such 
interfaces as tools for biosynthetic engineering.  
 
INTRODUCTION 
Type I modular polyketide synthases (PKSs) and nonribosomal peptide synthetases (NRPSs) 
are remarkable molecular machines that assemble natural products with a wide range of 
applications in medicine and agriculture.1 They typically consist of multiple protein subunits 
containing one or more catalytic domains that must interact with each other in a tightly 
defined manner to ensure biosynthetic fidelity. These interactions are frequently mediated by 
docking domains appended to the N- and/or C-termini of the subunits.2 One such example is 
the b-Hairpin Docking (bHD) domain, which has been found attached to the N-terminus of 
NRPS subunits in a handful of hybrid PKS-NRPS systems.3 bHD domains interact with short 
linear motifs (SLiMs) appended to the C-terminus of upstream PKS subunits, facilitating the 
recognition of acyl groups attached to an ACP domain by condensation (C) or heterocyclisation 
(Cy) domains in the NRPS subunit. The structures of excised bHD domains  from the tubulysin 
and rhabadopetide assembly line as well as a covalently-linked SLiM-bHD domain complex 
from rhabadopetide assembly line have been determined by NMR spectroscopy2,4. In 
addition, the X-ray crystal structure of a bHD-Cy di-domain from the EpoB NRPS subunit of the 
epothilone assembly line has been reported.3  
In the accompanying manuscript,5 we report that the PKS responsible for the assembly of the 
acyl chain in enacyloxin IIa, an antibiotic with promising activity against Acinetobacter 
baumannii,6 employs an unusual dual transacylation mechanism for product release. This 
 involves transfer of the fully-assembled polyketide chain from the acyl carrier protein (ACP) 
domain of the final PKS module (Bamb_5919) to a peptidyl carrier protein (PCP) domain in 
Bamb_5917 (Fig. 1a). Subsequent condensation of the polyketide chain with (1S, 3R, 4S)-3, 4-
dihydroxycyclohexane carboxylic acid (DHCCA) is catalysed by Bamb_5915, an enzyme with 
sequence similarity to NRPS C domains (Fig. 1a). Transacylation of the polyketide chain from 
the Bamb_5919 ACP domain to the Bamb_5917 PCP domain is catalysed by a non-elongating 
ketosynthase (KS0) domain appended to the C-terminus of Bamb_5919 (Fig. 1a). This is 
necessitated by the inability of Bamb_5915 to utilise acyl donors when they are attached to 
the Bamb_5919 ACP domain, indicating that specific protein-protein interactions facilitate the 
recognition of substrates bound to the Bamb_5917 PCP domain by Bamb_5915. 
Here we report extensive structural studies of Bamb_5915 and the Bamb_5917 PCP domain, 
which illuminate the molecular basis for their interaction. We show that a SLiM-bHD domain 
pair plays a key role in their productive association and provide new mechanistic insights into 
the conformational changes involved in binding and catalysis. Bioinformatics analyses reveal 
that SLiM-bHD domain pairs, previously identified in only a handful of systems, are 
widespread in NRPS and hybrid NRPS-PKS assembly lines, and likely facilitate the interaction 
of carrier protein domains with a range of catalytic domains. The productive interaction of a 
SLiM and a bHD domain from distantly related taxa illustrates the potential to exploit SLiM-
bHD domain interactions for the creation of novel biosynthetic pathways.  
 
 
 
  
Figure 1 Chain release in enacyloxin biosynthesis | a, Proposed mechanism for chain release from the 
enacyloxin PKS. Bamb_5917 has 214 amino acids appended to the N-terminus of the PCP domain 
(marked with ? in Fig. 1a), which appears  to be a non-functional remnant of a KS domain that is not 
involved in chain release (as demonstrated by enzymatic assays5). b, X-ray crystal structure of 
Bamb_5915. The bHD domain is coloured green, and the C- and N-terminal subdomains are coloured 
blue and grey, respectively. The “latch” region is cyan, the “floor loop” is yellow and the active site 
H205 residue is red. The loops blocking the acceptor entrance to the solvent channel are magenta and 
cyan. The inset panels show views of the secondary posterior and blocked acceptor side entrances.  c, 
Solution NMR structure of the Bamb_5917 PCP domain. d, Dynamine1 order parameter (S2) 
predictions, and 15N–{1H} NOE and 15N R2 relaxation measurements for the holo-Bamb_5917 PCP 
domain. 
  
RESULTS AND DISCUSSION  
X-ray crystal structure of Bamb_5915  
The 56 kDa Bamb_5915 protein consists of a C-terminal C domain and an N-terminal bHD 
domain (Fig. 1b & Supplementary Fig. 1-4; PDB ID: 6CGO). The C domain is a V-shaped 
pseudodimer with each subdomain harbouring the chloramphenicol acyltransferase fold7 and 
the conserved active site HHxxxD motif8 at their central interface (Fig. 1b). A phosphate ion is 
bound in the active site of the protein. A 30 Å channel runs through the centre of the C domain, 
allowing access to the active site from two separate faces (Supplementary Fig. 5). The 
entrance near the binding site for the Bamb_5917 PCP domain (the acyl donor entrance) is 
located at the anterior of the C domain, in accord with other NRPS C domain structures 
(Supplementary Figs 6 and 7). A second active site entrance is located at the posterior of the 
C domain and is defined by a groove between α-helix 6 of the N-terminal subdomain and the 
β-sheet of the C-terminal subdomain (Supplementary Fig. 5). Although the Bamb_5915 C 
domain structure is similar to other C domains, two features make it unique. First, the channel 
entrance adjacent to the canonical acyl acceptor PCP domain binding site (the acceptor side 
entrance) is obstructed by α-helix 4, and the loops between β-strands 13 and 14 (cyan in Fig. 
1b) and β-strand 12 and α-helix 9 (magenta in Fig. 1b; Supplementary Fig. 8 and Movie 1). 
Thus, either the acyl acceptor is delivered through the secondary posterior entrance, or a 
conformational change occurs at the acceptor entrance to allow substrate entry into the 
active site. Second, the “latch region” (V419-S454) in the C-terminal subdomain does not 
donate a β-strand to the β-sheet in the N-terminal subdomain as in other C domain structures, 
 but instead forms a largely unstructured loop (Supplementary Fig. 9). The “latch” β-strand 
observed in most other C domain structures has been suggested to disengage from the N-
terminal subdomain during either acyl donor binding or product release9. The Bamb_5915 
crystal structure provides the first observation of a “latch” in a disengaged state.  
An N-terminal bHD domain (green in Fig. 1b) with αββαα topology is appended to the C 
domain, similar to crystal structures of the heterocyclization domain from the EpoB subunit 
of the epothilone PKS-NRPS10. According to a Dali11 search, the Bamb_5915 bHD domain has 
high structural homology (Supplementary Fig. 10), but less than 35% sequence similarity to 
the bHD domains from EpoB10 and the TubC subunit of the tubulysin PKS-NRPS12. In the 
structures of the EpoB bHD-Cy di-domain and Bamb_5915 both the βHD domains and the 
linker regions connecting them to the downstream catalytic domains adopt distinct 
orientations (Supplementary Fig. 11). This suggests that the inter-domain linker is flexible,3 
allowing βHD domains to access multiple conformational states, which may facilitate PCP 
recognition.  
Solution NMR spectroscopic analysis of the Bamb_5917 PCP domain 
The structure of the 10.7 kDa apo-PCP domain of Bamb_5917 (i.e. without the substrate-
carrying phosphopantetheine (Ppant) prosthetic group) forms a four-helix bundle typical of 
such carrier proteins (Fig. 1c and Supplementary Fig. 12; PDB ID: 5MTI). The stable 
conformation of the Bamb_5917 PCP domain resembles the A/H state of the TycC3 PCP 
domain16 (Supplementary Fig. 12), also observed in most X-ray and NMR structures of carrier 
proteins17. The disordered termini of the PCP domain are highly mobile on the fast ps-ns 
timescale as indicated by low heteronuclear nuclear Overhauser effects (NOEs), transverse 
 relaxation rates (R2), and high longitudinal relaxation rates (R1) for these regions compared to 
the structured core (Fig. 1d and Supplementary Fig. 13). The overall rotational diffusion13 is 
consistent with a monomeric state, with a compact folded core and disordered termini 
(Supplementary Materials and Methods). The dynamic, disordered nature of the terminal 
regions is further confirmed by the low predicted S2 parameters (Fig. 1d and Supplementary 
Fig. 14; S2 of 1 and 0 indicate complete rigidity and unrestricted motion, respectively), typical 
chemical shift values for a random coil and a lack of long-range NOEs. S2 predictions suggest 
that the full-length Bamb_5917 protein exhibits similar dynamic behaviour. A few localised 
changes in 15N chemical shifts between the holo- and apo-forms of the Bamb_5917 PCP 
domain (BMRB 27304 & 34085; Supplementary Fig. 15), observed only near the Ppant 
attachment site, suggest that these two forms have nearly identical major conformations with 
similar dynamics on the fast ps-ns time scale (Supplementary Fig. 13). Notably, the C-terminus, 
which contains a docking domain, shows dynamic behaviour typical of an intrinsically 
disordered region (IDR). 
Interactions between Bamb_5915 and the Bamb_5917 PCP domain 
In the NMR titrations of the Bamb_5917 holo-PCP domain with both full-length Bamb_5915 
and its excised bHD domain the system is in slow to intermediate exchange14 (Supplementary 
Fig. 16). Higher than average local apparent association constants, Ka, in the titrations with 
the excised bHD domain identify a Short Linear Motif (SLiM; S307-R315)11 in the disordered C-
terminus of Bamb_5917 as the major interaction site (Fig. 2a-b). Other regions appreciably 
affected by binding of the bHD domain are located at the N-termini of α-helices 1 and 2, and 
loop 1 which connects these two helices (Fig. 2b). While the perturbation of adjacent surface 
 residues (A231 and T230 in α-helix 1) and I225 may indicate a secondary interaction interface 
with the bHD domain, most of the residues near loop 1 have buried side chains in direct 
contact with each other (Supplementary Fig. 17) suggesting conformational change upon 
binding as a more likely interpretation of the observed effects.  
 
Figure 2 Interactions between the Bamb_5917 PCP domain and Bamb_5915 | a, Local apparent Ka 
values as a function of residue obtained from NMR titrations of the Bamb_5917 PCP domain with 
Bamb_5915 and the excised βHD domain. The error bars represent two standard deviations over 1000 
iterations of Monte Carlo error analysis. b, Residues with local apparent Ka values higher than the 
average in the NMR titration with the excised Bamb_5915 βHD domain. c, Residues with local apparent 
Ka values higher than the average in the NMR titration with full length Bamb_5915. d, Changes in 
solvent accessibility of residues in the Bamb_5917 PCP domain upon binding to Bamb_5915 
determined by carbene footprinting mass spectrometry. Red, blue and cyan indicate, respectively, 
peptides that are masked (i.e. less solvent exposed), unchanged, and unmasked (i.e. more solvent 
exposed) as a result of complex formation. e, 13Ca chemical shift changes between the Bamb_5917 PCP 
domain in solution and in a sedimented complex with Bamb_5915, reflecting changes in local 
conformation in the complex. f, Changes in solvent accessibility of residues in Bamb_5915 upon 
binding to the Bamb_5917 PCP domain determined by carbene footprinting mass spectrometry. The 
colour key is the same as in d. The peptides for which proteolysis products were not detected are 
shown in grey. 
  
In the titrations of the Bamb_5917 PCP domain with full-length Bamb_5915 (Fig. 2c), in 
addition to the regions identified by the titrations with the excised bHD domain,  surface 
residues near the C-terminus of α-helix 1 (A238 and Q234) and the N-terminus of α-helix 2 
(Q256 and A263) also have above average local apparent Kas. These likely report on 
interactions with the catalytic domain of Bamb_5915. Indicators of conformational change 
near loop 1 extend further into the hydrophobic core (e.g. L229 on α-helix 1 and L287 on α-
helix 4) compared to the experiment with the isolated bHD domain.  
Binding of the SLiM to the bHD domain is further confirmed by the proportional increase in 
15N R2 values for the SLiM and the observation of a minor state in 15N Chemical Exchange 
Saturation Transfer (CEST) (exchange rate of 0.58 ± 0.02 s–1 and minor population of ~9%) 
when Bamb_5915 is present in solution (1:5 and 1:10 molar ratio; Supplementary Figs 18 and 
19). Typically, caution needs to be exercised in quantifying local apparent Kas from the rate of 
disappearance of signals in NMR titrations (Supplementary Figs 20 and 21)14. However, 
because the Kas obtained from signal growth in the titration with the excised bHD domain 
(Supplementary Fig. 22) are consistent with Ka > 106 M-1 (Kd < 1  µM) and the Ka for binding of 
the Bamb_5917 PCP domain to Bamb_5915 determined using biolayer interferometry is 
14x105 ± 4x105 M-1 (Kd = 0.7 ± 0.2  µM; Supplementary Fig. 23), it appears that the Kas obtained 
from peak disappearance for residues in the intrinsically disordered SLiM are dominated by 
binding events. 
We also conducted carbene footprinting15 to assess changes in the solvent accessibility of 
different residues as a result of binding of the Bamb_5917 PCP domain to Bamb_5915 
 (Supplementary Figs 24-26; raw data in Supplementary File 1). Masking indicative of a 
decrease in solvent accessibility upon binding is observed for peptides from the disordered 
C-terminus and a-helices 1 and 2 of the PCP domain (Fig. 2d). Unmasking of peptides from 
a-helices 3 and 4 is also observed (Fig. 2d) suggesting an increase of solvent accessibility for 
these regions as a result of a conformational change in the PCP domain upon binding.  
From the NMR titrations and carbene footprinting, we can identify three main regions of the 
PCP domain that interact directly with Bamb_5915: the C-terminal SLiM (S307-R315) and a-
helices 1 and 2. The unmasking of peptides from a-helices 3 and 4 of the PCP domain is 
consistent with conformational changes in these regions, rather than direct binding, as 
indicated by the NMR titrations.  
The carbene footprinting experiments aid identification of interaction sites and 
conformational changes in Bamb_5915. Digested peptides masked as a result of binding 
include α-helix 1 of the βHD domain, and terminal residues in a-helices 6, 10, 12 and 13 (Fig. 
2). The region masked in the βHD domain is adjacent to, and does not overlap with, the SLiM- 
βHD interface identified by NMR titrations for the isolated βHD domain from the tubulysin 
system (Supplementary Fig. 27). Interestingly, no statistically significant masking is observed 
for the β-hairpin, which is the expected binding interface for the SLiM4,12. One possible 
explanation for the lack of statistically significant masking of the β-hairpin could be its 
“flapping” motion observed in MD simulations, resulting in increased solvent exposure. If 
binding of the SLiM stabilizes the β-hairpin in a more open conformation, the two effects, 
binding and conformational change, would partially counteract each other. The masking of 
peptides from a-helices 10, 12 and 13 identifies a surface patch that could be an interaction 
 site for the globular part of the PCP domain. The masked A167-R175 peptide from a-helix 6 
is remote from the expected PCP binding site and is likely linked to a conformational change 
in Bamb_5915 upon binding. Finally, unmasking of the C-terminal part of the “latch” region 
(peptide A432-I460) suggests that Bamb_5915 undergoes a conformational change upon 
binding the Bamb_5917 PCP domain that leads to solvent exposure of this region.  
Further insights into conformational changes of Bamb_5917 PCP upon binding  
Binding of Bamb_5915 to the Bamb_5917 PCP domain does not seem to be a simple rigid 
body docking but rather involves conformational changes in both proteins. A conformational 
switch has been observed for the apo and holo-forms of the TycC3 PCP domain,16 but the 
relevance of this observation to assembly line function has been challenged17.  
To characterise the conformation of the holo-Bamb_5917 PCP domain-Bamb_5915 complex, 
which is invisible in solution due to size-related severe resonance broadening, we turned to 
60-100 kHz magic angle spinning solid-state NMR spectroscopy18. The de novo assignment of 
the signals in a sedimented19,20 70 kDa complex of the holo-Bamb_5917 PCP domain with 
Bamb_5915 was prevented by limited resolution and sensitivity but a set of tentative self-
consistent assignments was obtained by comparing the signals in solution and solid state 
spectra. We found that several characteristic signals for the bound form of the PCP domain 
in the sedimented complex appear to be in approximately the same position as in the solution 
NMR titrations with the excised βHD domain (assignment of these resonances in solution was 
made using the chemical shifts of the minor bound state in 15N CEST), e.g. R315 and V284 
(Supplementary Fig. 28). The residues in the SLiM and most residues in the globular part of 
the PCP domain, are largely immobilised in the Bamb_5917 PCP:Bamb_5915 complex, as 
 evidenced by the appearance of their signals in the dipolar coupling based correlation spectra 
(Supplementary Fig. 28). Most of the residues in the PCP domain for which the Ca resonances 
are shifted by more than 1 ppm, indicating conformational change, face the interior of the 
protein (Fig. 2e). The observed pattern supports the idea that the hydrophobic core of the 
PCP domain rearranges upon binding to Bamb_5915. This rearrangement involves loop 1, a-
helix 1 and a-helix 3. In addition, the Ca signal for V284, which has a chemical shift more 
consistent with a random coil than an a-helix (61.8 ppm in the complex compared to 67.7 
ppm in the free form; random coil value for Val is 62.121), suggests that this conformational 
change is accompanied by partial unwinding of a-helix 4 at its N-terminus.  
The conformational changes suggested by the solid-state NMR data and carbene footprinting 
experiments appear largely consistent with the overall conformational changes found in 0.5 
µs accelerated molecular dynamics22 (aMD) simulation of the holo-Bamb_5917 PCP domain. 
The rearrangement of the hydrophobic core in the simulation involves rotation and 
translation of a-helix 1 and a large conformational change in loop 1 (Fig. 3c and 
Supplementary Movie 5). The motion of loop 1 leads to increased solvent accessibility at the 
C-terminus of a-helix 3 and the N-terminus of a-helix 4, consistent with the unmasking 
observed in the carbene footprinting. 
  
Figure 3 Accelerated Molecular Dynamics (aMD) simulations of Bamb_5915 and the Bamb_5917 PCP 
domain, and model of the Bamb_5917_PCP domain:Bamb_5915 complex. | a, Distances between 
centres of mass of residues used to track conformation of Bamb_5915 during 1 μs aMD simulations. 
P103-I293 reports on the degree of association between C- and N-terminal subdomains. G425-P97 and 
G423-V99 report on the distances from the N-terminal subdomain b-strand to residues on the C-
terminal subdomain latch. b, Conformations of Bamb_5915 with closed (left) and open (right) acceptor 
channels observed in 1 μs aMD simulations. The conformation with the open acceptor channel is 
stabilised by donation of the latch to the N-terminal subdomain. Residues in the active site motif are 
red, the bHD domain is light blue, the latch is cyan, b-strands 3 and 9 are green, the floor loop is yellow 
and a-helix 6 is orange. The yellow lines indicate hydrogen bonds between the latch (cyan) and b-
strand 3 (green). c, Frames at 0 and 400 ns from 0.5 μs aMD simulations, illustrating the overall 
conformational changes of the holo-Bamb_5917 PCP domain. α-Helices 1, 2, 3, 4 are coloured red, 
green, blue and yellow, respectively. Red and grey arrows indicate the approximate direction of 
movement of α-helix 1 and loop 1, respectively. The Ppant (not shown) is attached to the Ser residue 
indicted with *. d, A model of the holo-Bamb_5917 PCP domain:Bamb_5915 complex based on docking 
the Bamb_5915 X-ray crystal structure and the structure of the holo-Bamb_5917 PCP domain observed 
in a 180 ns frame from the aMD simulations. The distance of 5.2 Å from the Ppant thiol to the active 
site H205 residue in the model of the complex suggests that conformational changes similar to the 
 ones observed in the aMD simulation of Bamb_5915 are required for the condensation reaction to 
occur. Additional conformers of the Bamb_5917 PCP domain from the cluster of best solutions from 
the docking simulation are shown as silhouettes. 
 
Further insights into conformational changes of Bamb_5915 upon binding  
Molecular dynamics (MD) simulations19 shed light on the conformational changes of 
Bamb_5915. One of the most notable conformational changes observed in a standard 100 ns 
MD simulation of Bamb_5915 is modulation of the degree of association between the N- and 
C-terminal subdomains (Supplementary Fig. 29), which has been proposed for other 
condensation domains to have a potentially significant role in catalysis9,23,24. Interestingly, this 
overall conformational change appears to be correlated with changes to the accessibility of 
the active site entrances. In particular, an entrance on the acyl acceptor side is created when 
the degree of association between the N- and C-terminal subdomains increases 
(Supplementary Fig. 29). This implies that the unusual DHCCA acyl acceptor employed by 
Bamb_5915 can access the active site through the same route as in C domains that use more 
conventional aminoacyl-PCP domains as acyl acceptors (Supplementary Fig. 8). To capture 
slower large-scale motions, we also performed a 1 µs aMD simulation on Bamb_5915 (Fig. 3) 
22,25. Hydrogen bonds are formed between residues from the “latch” region of the C-terminal 
subdomain (G424 and G423) and residues in the N-terminal subdomain (P97 and V99, 
respectively) in this simulation (Fig. 3a), resulting in a conformation similar to that observed 
in other structures of C domains, but with a smaller interface between the N- and C-terminal 
subdomains. The “donation” of the “latch” to the N-terminal subdomain appears to stabilise 
the high degree of association between the C- and N-terminal subdomains and consequently 
 the open state of the acyl acceptor entrance (Supplementary Movie 2). The C domain appears 
to operate a pair of interlocked shutter valves: the size of the acyl acceptor entrance is 
inversely correlated with the size of the opening on the acyl donor side. The extent of the 
opening depends on the conformations of the “latch” and the loop between β-strand 12 and 
α-helix 9 for the acyl acceptor entrance and the “latch” and “floor loop” region24 (loop 
between b-strands 11 and 12, in yellow in Figs 3b and 1b) for the acyl donor entrance. The 
corresponding regions are highly variable between different condensation domains and may 
contribute to the substrate specificity of the enzymes by influencing the state of the active 
site entrances. 
Assuming that binding of the Bamb_5917 PCP domain stabilises Bamb_5915 in conformations 
similar to the ones observed in the aMD simulation, we can explain the results of the carbene 
footprinting experiments for regions with changing solvent accessibility that are remote from 
the expected binding site. For example, opening of the acyl acceptor channel leads to 
increased solvent accessibility of the C-terminal portion of the “latch”, consistent with the 
unmasking of that region (Supplementary Fig. 30). Moreover, opening of this channel is 
accompanied by partial burial of a-helix 6 (orange in Fig. 3b; Supplementary Fig. 31), and 
masking of this region (Fig. 2d). The aMD simulations also suggest that masking of a-helix 12 
can be, at least partially, attributed to conformational change rather than binding 
(Supplementary Fig. 32). Stabilisation of the “open acceptor channel conformation” of 
Bamb_5915 by binding of the donor PCP domain, suggests that the acyl acceptor may not be 
able to access the active site until the acyl donor is bound. However, further experiments will 
be required to test this hypothesis. 
 Examination of the structures of Bamb_5915 homologues, including condensation, 
epimerisation, heterocyclisation and X domains, suggests that the correlation between the 
degree of association of the C- and N-terminal subdomains and the accessibility of the acyl 
donor and acceptor active site entrances may be a general feature (Supplementary Fig. 33). 
In examples with a low degree of association between the N- and C-terminal subdomains the 
acyl acceptor channel is closed and the acyl donor channel is open, whereas in cases where 
the degree of subdomain association is high the converse is observed. In intermediate 
conformational states both entrances are open. 
Interaction model for the Bamb_5917 PCP-Bamb_5915 complex 
We used High Ambiguity Driven biomolecular DOCKing (HADDOCK) to produce a series of 
models of the dynamic Bamb_5917 PCP domain:Bamb_5915 complex26,27(Supplementary Fig. 
34 & 35). We used the X-ray crystal structure of Bamb_5915 and conformations sampled from 
the aMD simulations of the holo-Bamb_5917 PCP domain as the starting point. 
Conformational changes in the PCP domain are required to position the thiol group of the 
Ppant arm close to the highly conserved H205 active site residue. One model of the complex 
employing a conformation that allows the Ppant-bound substrate to be positioned close to 
H205 is shown in Fig. 3d. The distance between the thiol group of the Ppant arm and the 
conserved active site H205 residue is ~5 Å. The orientation of the Bamb_5917 PCP domain in 
this model differs from those observed for the PCP domains in the crystal structures of the 
GrsA PCP-E and TqaA PCP-CT di-domains (Supplementary Fig. 36).28,29 The R420 side chain 
appears to stabilise the “donated latch” conformation, in a similar way to His and Asn residues 
in the structure of the TqaA PCP-CT di-domain (Supplementary Fig. 37).28  
 SLiM-bHD domain interactions are important for chain release 
Using (1S, 3R, 4S)-3-amino-4-hydroxycyclohexane-1-carboxylic acid (AHCCA) as an acyl 
acceptor,5 we assessed the ability of Bamb_5915 to off-load the acetyl group from a 
Bamb_5917 PCP domain construct lacking the C-terminal SLiM. Relative to the full-length 
acetylated Bamb_5917 PCP domain, the amount of N-acetyl-AHCCA produced in this reaction 
was substantially reduced (Fig. 4a-d). This indicates that the SLiM plays an important role in 
recruitment of the PCP domain to the C domain. We were unable to conduct the converse 
experiment in which the ability of full length Bamb_5915 to catalyse chain release is compared 
to its isolated C domain, because Bamb_5915 constructs lacking the bHD domain were 
insoluble in E. coli. We thus investigated the ability of the isolated bHD domain to inhibit the 
condensation reaction. A decrease in the quantity of N-acetyl-AHCCA formed was observed 
as the concentration of the isolated bHD domain was increased (Fig. 4e and Supplementary 
Fig. 38). Analogous results were obtained when a synthetic SLiM peptide was used in place of 
the isolated bHD domain (Fig. 4f and Supplementary Fig. 38). Together, these data confirm 
that the interaction of the SLiM with the bHD domain plays an important role in chain release 
from the enacyloxin PKS. However, because residual product formation is observed in all of 
these experiments, it is clear that the globular portion of the PCP domain can engage in 
productive protein-protein interactions with the C domain. It thus appears that the purpose 
of the SLiM-bHD domain interaction is to increase the effective concentration of the acyl 
donor. 
 
 
  
Figure 4 Extracted ion chromatograms from UHPLC-ESI-Q-TOF-MS analyses of chain release reactions 
| a, chromatogram for the authentic standard of N-acetyl-AHCCA. b-c, chromatograms for Bamb_5915 
catalysed N-acetylation of AHCCA with the acetylated Bamb_5917 PCP domain (b), or the acetylated 
Bamb_5917 PCP domain lacking the SLiM (Bamb_5917 PCPDSLiM) (c). d, chromatogram for a control 
reaction from which Bamb_5915 was omitted. e-f, chromatograms for competition assays for the same 
experimental set up as in (b) but with increasing amounts of the excised Bamb_5915 bHD domain (e) 
or Bamb_5917 SLiM peptide (f). All reactions were performed in triplicate. 
 
SLiM-bHD domain pairs are found in numerous assembly lines  
We used the sequences of the Bamb_5915, TubC12 and EpoB10 bHD domains to create a 
profile hidden Markov model (pHMM). The MIBIG30 database was searched using this pHMM 
and the hits were used to refine the model (Fig. 5a). To identify the SLiM partners of these 
 bHD domains, we first assumed co-linearity between the order of subunits in assembly lines 
and the order of the genes encoding them. We then identified subunits upstream of those 
with an N-terminal bHD domain, which contain C-terminal sequences that do not conform to 
pHMMs for known PKS and NRPS domains, and are predicted by IUPRED to be disordered31. 
In these systems the disordered C-terminal regions are rich in charged residues (typically 
glutamate, but other charge patterns are observed; Fig. 5a), as observed for the SLiMs that 
interact with the Bamb_5915, TubC and EpoB bHD domains. In a few cases, we manually 
examined gene clusters to identify those encoding a protein with a C-terminal SLiM that don’t 
conform to the co-linearity assumption. Using this procedure, >80 SLiM-bHD domain pairs 
were identified in the MIBIG database,30 with some assembly lines containing multiple 
examples. Among these were 58 pathways for known metabolites, including several 
clinically-used antibiotics and anticancer agents (Fig. 5b and Supplementary Table 13). 
Several subclasses of SLiM-bHD domain pairs were identified, based on the charge pattern of 
the SLiM and the type of catalytic domain connected to the bHD domain, for example dual 
epimerisation/condensation (C/E) domains, which are associated with a characteristic SLiM 
(Supplementary Fig. 39). 
When this procedure was applied to the Genbank database32 >1400 SLiM-bHD domain pairs 
were identified (Supplementary File 1), including additional pathways for known metabolites 
not in the MIBiG database (Supplementary Table 14). This shows that such subunit interfaces 
are not only much more prevalent than previously appreciated, but also mediate 
communication between a wide range of catalytic domains. SLiMs were identified at the C-
termini of oxidase and Cy domains, in addition to ACP and PCP domains (Fig. 5c), and bHD 
 domains were found not only at the N-termini of C and Cy domains, but also C/E domains, 
thioesterases, thioester reductases (including cases where a b-lactamase-like domain is fused 
to the N-terminus of the bHD domain), halogenases, methyltransferases and other proteins 
of unknown function (Fig. 5c). In some cases, a single SLiM appears to recruit multiple 
catalytic subunits to the same PCP domain, e.g. in the cyanopeptolin NRPS a C-terminal SLiM 
in McnC likely interacts with N-terminal βHD domains in NRPS and halogenase subunits 
encoded by mcnE and mcnD, respectively.  
  
Figure 5 Bioinformatics analyses reveal that SLiM-bHD domain pairs mediate subunit interactions in 
numerous assembly lines | a, Sequence logos for SLiMs and bHD domains from all the hits in the MIBIG 
database. b, Examples of metabolites produced by assembly lines containing SLiM-bHD domain 
boundaries. Bonds in black are formed in enzymatic reactions dependent on SLiM-bHD domain 
communication. c, Examples of domain types between which the communication was found to be 
facilitated by SLiM-bHD domain pairs. Only examples with multiple hits in the database are included. 
 PCP – peptidyl carrier protein, ACP – acyl carrier protein, LCL – condensation domain accepting L-
configured donor and acceptor aminoacyl thioesters, C/E – bifunctional condensation-epimerisation 
domain, Cy – heterocylisation domain, H- halogenase, TR – thioester reductase, TE – thioesterase. 
 
Heterologous SLiM-bHD domain pairs are compatible 
The abundance and diversity of SLiM-bHD domain interfaces in biosynthetic assembly lines 
suggests it may be possible to exploit heterologous interfaces for the production of novel 
natural product hybrids. As an initial test of feasibility, we examined whether Bamb_5915 
could interact productively with a PCP domain from an NRPS subunit (Sven_0512) in 
Streptomyces venezuelae involved in watasemycin assembly (Fig. 6)33. The SLiM appendend 
to this PCP domain is very similar to that in Bamb_5917. The pattern of negatively charged 
and hydrophobic residues are largely preserved, but it lacks the C-terminal Arg residue (Fig. 
6c; Supplementary Fig. 40). In its native context, this SLiM interacts with a bHD domain (~35% 
sequence identity with the Bamb_5915 bHD domain; Supplementary Fig. 41) appended to a 
Cy domain. In NMR titrations of the Bamb_5917 PCP domain with the excised bHD domain 
from Sven_0517, residues in the SLiM were observed to interact strongly (Supplementary Fig. 
42-43). Incubation of the acetylated Sven_0512 PCP domain with Bamb_5915 and AHCCA led 
to the formation of N-acetyl-AHCCA (Fig. 6a), demonstrating that SLiMs and bHD domains 
from heterologous systems can cross-talk productively. The important role played by the 
interaction of the heterologous SLiM with the bHD domain is highlighted by the progressive 
reduction in product formation when increasing concentrations of isolated Sven_0512 SLiM 
or Bamb_5915 bHD domain are added to the reaction mixtures (Fig. 6c,d).  
 
  
Figure 6 Heterologous SLiMs and bHD domains can interact productively | a, Bamb_5915 C domain-
catalysed N-acetylation of AHCCA with the acetylated Sven_0512 PCP domain (40% sequence identity 
with the Bamb_5917 PCP domain) illustrating that the enacyloxin and watasemycin assembly lines can 
cross-talk. b, Control reaction in the absence of Bamb_5915. c-d, Competition assays for same 
experimental set up as in a but with increasing amounts of the excised Bamb_5915 bHD domain (c) or 
Sven_0512 SLiM peptide (d). e, Sequence alignment of SLiMs and bHD domains (35% sequence 
identity) from the enacyloxin and watasemycin assembly lines. The underlined residues represent the 
sites in the Bamb_5917 SLiM that interact with the Bamb_5915 bHD domain. 
 
CONCLUSIONS 
Previous structural studies have focused on excised bHD domains and the juxtaposition of 
such domains to downstream Cy domains2-4. The structural relationship between the SLiM 
interaction partners for bHD domains and their upstream carrier protein domains has 
 hitherto not been investigated. Our work shows that the SLiM in Bamb_5917 forms part of a 
larger IDR appended to the C-terminus of the PCP domain. Together with our recent work on 
another type of IDR-embedded SLiM, which facilitates subunit interaction in trans-AT PKSs 
by binding to the surface of a DH domain34, our results suggest that IDRs may be more widely 
exploited for inter-subunit communication in biosynthetic assembly lines than previously 
thought. 
A combination of structural, biophysical and computational analyses of the Bamb_5917 PCP-
SLiM di-domain and Bamb_5915 enabled us to generate extensive new insights into 
interactions across SLiM-bHD domain interfaces. In particular, we established that both 
partners undergo conformational changes upon binding, which may play an important role 
in C domain catalysis by controlling sequential access of substrates to the active site. 
Compared to subunits from other systems that communicate via SLiM-bHD domain pairs, 
Bamb_5917 and Bamb_5915 are relatively small. This, coupled with the fact that the 
Bamb_5915 C domain utilizes a soluble, rather than carrier protein bound acyl acceptor, and 
tolerates a range of acyl donors,5 makes Bamb_5917/Bamb_5915 an attractive model system 
for future efforts aimed at exploring the specificity and engineer-ability of the SLiM-bHD 
domain interface. 
The pHMM for bHD domains developed in this work reveals that SLiM-bHD domain pairs 
mediate subunit communication in a far wider range of NRPS and NRPS-PKS systems than 
previously appreciated. Such systems include the assembly lines for bacitracin, romedepsin, 
bleomycin and epothilone, all of which are approved antibacterial or anticancer drugs, in 
addition to cryptophicin, an analogue of which reached phase II clinical trials, but was 
 withdrawn due to side effects. The fact that the Sven_0512 PCP-SLiM di-domain is able to 
interact productively with the Bamb_5915 bHD-C di-domain is remarkable in light of the 
divergent taxonomic origin (Gram-positive Actinobacteria and Gram-negative 
Betaprotobacteria, respectively) and biosynthetic nature of the watasemycin and enacyloxin 
assembly lines. This finding highlights the potential for SLiM-bHD domain interfaces to be 
exploited in biosynthetic engineering approaches to the production of novel natural product 
derivatives with enhanced therapeutic potential. Our pHMM also revealed that bHD domains 
are fused to a far wider range of enzymes than canonical NRPS C/Cy domains. Coupled with 
the ability of SLiMs and bHD domains from heterologous systems to recognize each other, 
this suggests it may be possible to harness SLiM-bHD domain interactions for the de novo 
creation of biosynthetic pathways to metabolic products hitherto unknown in Nature.  
 
METHODS SUMMARY   
Materials and methods are detailed in the supplementary information. 
 
Data availability. The structures of the Bamb_5917 PCP domain and Bamb_5915 are available 
from the PDB (accession IDs: 5MTI and 6CGO, respectively). NMR assignments for the apo and 
holo-Bamb_5917 PCP domain are available from the BMRB (Accession IDs: 34085 and 27304, 
respectively). Raw NMR and BLI data can be obtained from 
http://wrap.warwick.ac.uk/123013/. The remaining data supporting the findings of this study 
are included in the supporting information or are available from the corresponding authors 
on request. All biological materials are available from the authors on request. 
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